Clinical Trial Update: A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. [Phase 3]

View source ↗

Summary

This is a Phase 3 long-term safety trial evaluating centanafadine in children and adolescents with attention-deficit/hyperactivity disorder; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING